Terpenoid ID | TKC169457 | |
Cell line | 0 | |
Protein target | 8 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 13 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC169457 | P18031 | Tyrosine-protein phosphatase non-receptor type 1 | PTPN1 | 0 | nM | IC50 |
TKC169457 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 2239 | nM | Potency |
TKC169457 | P51450 | Nuclear receptor ROR-gamma | Rorc | 0 | nM | Potency |
TKC169457 | P42858 | Huntingtin | HTT | 1000 | nM | Potency |
TKC169457 | P36873 | Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | PPP1CC | 0 | nM | IC50 |
TKC169457 | Q8AWE3 | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | 0 | nM | IC50 | |
TKC169457 | P97697 | Inositol monophosphatase 1 | Impa1 | 40 | nM | Potency |
TKC169457 | Q15172 | Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform | PPP2R5A | 0 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 | PTN1_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P18031 | PTN1_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 | PTN1_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P18031 | PTN1_HUMAN | Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 | PTN1_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 | PTN1_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 | PTN1_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P42858 | HD_HUMAN | Choreiform disorder [ICD-11: 8A01] |